To Consolidate or Network: For Laboratories, That's the Question
Consolidation lowers operating expenses, a factor crucial in remaining competitive. But it cannot directly offset the losses that stem from the ongoing decline in the volume of inpatient testing as more health care services move to the ambulatory clinic arena. Networking, in contrast, allows laboratories to exploit the fixed cost aspects of their business by increasing volume, but it cannot bring down operating expenses enough to make members competitive with highly efficient independent reference la
You may also be interested in...
Hospital laboratory consolidation, underway for several years, is having mixed success as the market shifts. For suppliers, things are unlikely to settle down soon. Successful labs claim to be committed to a common vision and to swift action to institute painful changes. But other labs are stymied by politics, lack of top management support, and reluctance to make difficult decisions quickly. Manufacturers' expectations that consolidation would lead to standardization of equipment and a winner-take-all mentality are starting to come to pass. But the customer base continues to be in more flux than expected.
New report shows average out-of-pocket cost per prescription of $10.67 in 2019 was unchanged from 2018. But while the number of dispensed drugs barely increased, sales jumped more than 5%.
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.